NSC |
Compound |
Enrichment |
Correlation |
NSC 688228 |
Null |
0.012942183459279 |
0.26505406 |
NSC 693322 |
Hydrazinecarbothioamide, 2,2'-(1,2-ethanediylidene)bis[N,N-dimethyl- |
0.012942183459279 |
0.3766551 |
NSC 700862 |
4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- |
0.012942183459279 |
0.34173512 |
NSC 718781 |
Erlotinib hydrochloride |
0.012942183459279 |
-0.16093256 |
NSC 719667 |
7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one |
0.012942183459279 |
0.031020773 |
NSC 720320 |
1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole |
0.012942183459279 |
-0.070245892 |
NSC 720497 |
Null |
0.012942183459279 |
0.072491436 |
NSC 726217 |
Combretastatin A4-analogue |
0.012942183459279 |
0.4280242 |
NSC 726442 |
4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride |
0.012942183459279 |
0.28382875 |
NSC 728078 |
2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide |
0.012942183459279 |
0.35931749 |